MYH11 and non-small cell lung carcinoma: Furthermore, multiple studies have confirmed that various CAF subsets, including POSTN+ CAFs, COL11A1+ CAFs, FAP+αSMA+ CAFs, and MYH11+αSMA+ CAFs, play critical roles in mediating ICI resistance in NSCLC patients (29, 53, 128).